HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance

Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)

January 27, 2025 11:46 AM EST

Mizuho analyst Ann Hynes reiterated an Outperform rating and $425.00 price target on HCA Healthcare Inc (NYSE: HCA).

The analyst comments "We are maintaining our price target of $425, and our 2025E-2026E adjusted EBITDA estimates, while increasing our 2025E-2026E adjusted EPS estimates driven by... More

HCA Healthcare Inc (HCA) PT Lowered to $404 at Leerink Partners

January 27, 2025 6:23 AM EST

Leerink Partners analyst Whit Mayo lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $404.00 (from $460.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: Reiterate Outperform rating. 4Q24 results brought forth a continuation of strong demand trends, good cost controls and... More

HCA Holdings (HCA) Tops Q4 EPS by 8c, Offers Guidance, Approves $10B Buyback

January 24, 2025 7:34 AM EST

HCA Holdings (NYSE: HCA) reported Q4 EPS of $6.22, $0.08 better than the analyst estimate of $6.14. Revenue for the quarter came in at $18.29 billion versus the consensus estimate of $18.23 billion.

The HCA Healthcare, Inc. Board of Directors has authorized an additional share... More